Cell Source, Inc.
Income Statement
| Line Item | FY2026 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | $1.9M | $1.3M | $834.9K | $2.5M | $274.9K |
| SG&A Expense | — | $1.9M | $2.6M | $2.2M | $2.7M | $2.6M | $1.2M | $1.3M |
| Operating Income | — | $-3.8M | $-4.3M | $-4.2M | $-4.0M | $-3.6M | $-3.8M | $-2.0M |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | $629.2K | $457.4K | $228.8K | $-219.1K |
| Pretax Income | — | $-4.5M | $-5.3M | $-5.2M | $-5.5M | $-4.6M | $-4.5M | $-2.1M |
| Income Tax Expense | — | — | — | — | — | $0 | $0 | — |
| Net Income | — | $-4.5M | $-5.3M | $-5.2M | $-5.5M | $-4.6M | $-4.5M | $-2.1M |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | — | $-0.14 | $-0.17 | $-0.18 | $-0.19 | $-0.19 | $-0.18 | $0.09 |
| EPS (Diluted) | — | $-0.14 | $-0.17 | $-0.18 | $-0.19 | $-0.19 | $-0.18 | $0.09 |
| Shares Outstanding (Basic) | 67.9M | 41.9M | 37.8M | 34.8M | 33.1M | 32.5M | 27.1M | 26.1M |
| Shares Outstanding (Diluted) | 67.9M | 41.9M | 37.8M | 34.8M | 33.1M | 32.5M | 27.1M | 26.1M |
| Dividends Per Share | — | — | — | — | — | — | — | — |